基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Licenciada en Investigación Biomédica Básica- UNAM
Doctorado (PhD) en Ciencias Biomédicas: Inmunología - Mayo Graduate School Mayo Clinic, Rochester, Minnesota.
Experience as an academic researcher at UNAM: Instituto de Investigaciones Biomédicas (IIB), Fisiología Celular (IFC) and Biotecnología (IBt). Experience as medical researcher at Institutos Nacionales de Cancerología (INCan) and Medicina Genómica (INMEGEN).
Member of Sistema Nacional de Investigadores (SNI) from 2004 to 2016.
Contributions on metabolic regulation, inmunology, infectious diseases and genomics of human and mice.
PhD work identified two genes asociated to susceptibility to an infectious disease in mouse: Babr y Tccr1, through the integration of classical genetic tools and molecular genomic analysis of polymorphisms.
I coordinated the database of samples and clinical data in the collaborative project-INMEGEN-UNAM-Broad Institute-Instituto Carlos Slim de la Salud that successfully identified a genomic risk factor for type-2 diabetes in Mexican population that was introgressed from Neandertals (published in Nature in 2014).
I established the Gerencia de Investigación Genómica at Landsteiner Scientific, coordinating preclinical genomics and drug-discovery projects as well as clinical trials on pharmacogenomics with a focus of appropriateness for México.
At PiSA Biotec, I coordinated preclinical and clinical research on biotechnological drugs developed as biosimilars according to Mexican (COFEPRIS) and international standards (FDA/EMA).
Afterwards, I turned my attention and energy to contribute to the implementation of evidence-based health policies, as a public servant at Mexico Ministry of Health. I worked at CCINSHAE (Mexican equivalent of NIH), coordinating the logistics of the Expert Review Boards that evaluated COVID therapeutics and vaccines.
Currently I work at the National Health Council (Consejo de Salubridad General), performing technical reviews of dossiers on drugs and medical equipment as part of the process for consideration to adoption as part of the National Essential List of Health Supplies (Compendio Nacional de Insumos para la Salud). Additionally, I oversee international commitments related to global health, including antimicrobial resistance and surveillance of toxicity by lead and mercury.
I contribute technical expertise to initiatives on autism, palliative care, science integrity and bioethics.
Research Interests
Papers共 20 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Irma Aguilar-Delfín,Rogelio de Jesús Martínez-Sámano, César Alberto Cruz-Santiago,José Ignacio Santos-Preciado
Salud Pública de Méxicono. 5 (2021): 682-685
Irma Aguilar-Delfin,Rogelio De Jesus Martinez-Samano, Cesar Alberto Cruz-Santiago,Jose Ignacio Santos-Preciado
Cited0Views0Bibtex
0
0
Rafael Velazquez Cruz,Silvia Jimenez Morales,Julian Ramirez Bello,Irma Aguilar Delfin, Guadalupe Salas Martinez,Vicente Baca Ruiz,Lorena Orozco
Cited25Views0Bibtex
25
0
Load More
Author Statistics
#Papers: 17
#Citation: 1260
H-Index: 10
G-Index: 17
Sociability: 4
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn